Tag: China
Aopeng Medical completes clinical trial of robotic-assisted peripheral artery intervention of iliac...
Aopeng Medical’s Allvas endovascular intervention surgical robot has successfully completed a first-in-human clinical evaluation of robot-assisted peripheral artery intervention of an iliac artery in the Department of Vascular Surgery at Shanghai Changhai Hospital.
The procedure was performed by Qing-Sheng...
CEC@CX
In collaboration with the China Endovascular Course (CEC), at Charing Cross Symposium (CX; 15–18 April, London, UK) played host to CEC@CX. Wei Guo (Beijing,...
New analysis suggests peripheral artery disease affects 42–60 million Chinese citizens
A new analysis published by The Sage Group has concluded that 42–60 million Chinese citizens are afflicted by peripheral artery disease (PAD), with 5.6–6.3...
Castor branched aortic stent graft gains CFDA approval
The Castor branched aortic stent graft system, developed by MicroPort Endovascular, has obtained the regulatory approval from China Food and Drug Administration (CFDA), formally...
Lombard Medical and MicroPort Scientific Corporation finalise strategic partnership agreements
Lombard Medical and MicroPort Scientific Corporation have finalised the definitive agreements to their strategic partnership first announced on 19 December 2016.
The partnership will allow Lombard to accelerate...
Promising 12- and 24-month East Asian experiences for drug-coated balloons
Results from two Asian studies presented at LINC 2017 (24–27 January, Leipzig, Germany), show encouraging outcomes for drug-coated balloon versus percutaneous transluminal angioplasty treatment...
